Clinical Trial Update: Neuroprotection by Cannabinoids in Huntington's Disease [Phase 2]

View source ↗

Summary

A Phase 2 Huntington's disease trial evaluating neuroprotection by cannabinoids has completed. The update does not include detailed results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• Cannabinoids (cannabinoids)

Snippet

Sponsor: Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | Conditions: Huntington's Disease | Phase 2 | Status: COMPLETED